The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Plasma Albumin Market Research Report 2025
Synopsis
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
Global Plasma Albumin market is projected to reach US$ 8367.1 million in 2029, increasing from US$ 5110 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Plasma Albumin market research.
The plasma albumin market is primarily driven by the increasing demand for albumin in various medical applications. Albumin, a crucial protein found in blood plasma, plays a vital role in maintaining osmotic pressure, transporting nutrients, and regulating pH levels. As a result, it finds extensive use in therapeutic treatments for conditions like hypovolemia, burns, liver cirrhosis, and septic shock. Additionally, the rising prevalence of chronic diseases and surgical procedures further fuels the demand for albumin as a vital component in various medical products and therapies.However, the market also faces challenges, such as the limited availability of human plasma-derived albumin and the strict regulatory guidelines for its collection and purification. Ensuring a stable and adequate supply of albumin can be challenging, especially during times of high demand or unforeseen events. Moreover, the development of alternative albumin sources, such as recombinant human albumin, presents both opportunities and challenges for the market. Overcoming these obstacles through advanced production methods, research, and collaboration within the healthcare industry will be essential in meeting the growing demand and maintaining a sustainable plasma albumin market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Plasma Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Segment by Type
20-25% Concentrations
5% Concentrations
Segment by Application
Therapeutics
Excipient
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Plasma Albumin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
Global Plasma Albumin market is projected to reach US$ 8367.1 million in 2029, increasing from US$ 5110 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Plasma Albumin market research.
The plasma albumin market is primarily driven by the increasing demand for albumin in various medical applications. Albumin, a crucial protein found in blood plasma, plays a vital role in maintaining osmotic pressure, transporting nutrients, and regulating pH levels. As a result, it finds extensive use in therapeutic treatments for conditions like hypovolemia, burns, liver cirrhosis, and septic shock. Additionally, the rising prevalence of chronic diseases and surgical procedures further fuels the demand for albumin as a vital component in various medical products and therapies.However, the market also faces challenges, such as the limited availability of human plasma-derived albumin and the strict regulatory guidelines for its collection and purification. Ensuring a stable and adequate supply of albumin can be challenging, especially during times of high demand or unforeseen events. Moreover, the development of alternative albumin sources, such as recombinant human albumin, presents both opportunities and challenges for the market. Overcoming these obstacles through advanced production methods, research, and collaboration within the healthcare industry will be essential in meeting the growing demand and maintaining a sustainable plasma albumin market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Plasma Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Segment by Type
20-25% Concentrations
5% Concentrations
Segment by Application
Therapeutics
Excipient
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Plasma Albumin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Plasma Albumin Market Overview
1.1 Product Overview and Scope of Plasma Albumin
1.2 Plasma Albumin Segment by Type
1.2.1 Global Plasma Albumin Market Value Comparison by Type (2023-2029)
1.2.2 20-25% Concentrations
1.2.3 5% Concentrations
1.3 Plasma Albumin Segment by Application
1.3.1 Global Plasma Albumin Market Value by Application: (2023-2029)
1.3.2 Therapeutics
1.3.3 Excipient
1.3.4 Other
1.4 Global Plasma Albumin Market Size Estimates and Forecasts
1.4.1 Global Plasma Albumin Revenue 2018-2029
1.4.2 Global Plasma Albumin Sales 2018-2029
1.4.3 Global Plasma Albumin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Plasma Albumin Market Competition by Manufacturers
2.1 Global Plasma Albumin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Plasma Albumin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Plasma Albumin Average Price by Manufacturers (2018-2023)
2.4 Global Plasma Albumin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Plasma Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma Albumin, Product Type & Application
2.7 Plasma Albumin Market Competitive Situation and Trends
2.7.1 Plasma Albumin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasma Albumin Players Market Share by Revenue
2.7.3 Global Plasma Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma Albumin Retrospective Market Scenario by Region
3.1 Global Plasma Albumin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Plasma Albumin Global Plasma Albumin Sales by Region: 2018-2029
3.2.1 Global Plasma Albumin Sales by Region: 2018-2023
3.2.2 Global Plasma Albumin Sales by Region: 2024-2029
3.3 Global Plasma Albumin Global Plasma Albumin Revenue by Region: 2018-2029
3.3.1 Global Plasma Albumin Revenue by Region: 2018-2023
3.3.2 Global Plasma Albumin Revenue by Region: 2024-2029
3.4 North America Plasma Albumin Market Facts & Figures by Country
3.4.1 North America Plasma Albumin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Plasma Albumin Sales by Country (2018-2029)
3.4.3 North America Plasma Albumin Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Plasma Albumin Market Facts & Figures by Country
3.5.1 Europe Plasma Albumin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Plasma Albumin Sales by Country (2018-2029)
3.5.3 Europe Plasma Albumin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Albumin Market Facts & Figures by Country
3.6.1 Asia Pacific Plasma Albumin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Plasma Albumin Sales by Country (2018-2029)
3.6.3 Asia Pacific Plasma Albumin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Plasma Albumin Market Facts & Figures by Country
3.7.1 Latin America Plasma Albumin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Plasma Albumin Sales by Country (2018-2029)
3.7.3 Latin America Plasma Albumin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Plasma Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Albumin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Plasma Albumin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Plasma Albumin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plasma Albumin Sales by Type (2018-2029)
4.1.1 Global Plasma Albumin Sales by Type (2018-2023)
4.1.2 Global Plasma Albumin Sales by Type (2024-2029)
4.1.3 Global Plasma Albumin Sales Market Share by Type (2018-2029)
4.2 Global Plasma Albumin Revenue by Type (2018-2029)
4.2.1 Global Plasma Albumin Revenue by Type (2018-2023)
4.2.2 Global Plasma Albumin Revenue by Type (2024-2029)
4.2.3 Global Plasma Albumin Revenue Market Share by Type (2018-2029)
4.3 Global Plasma Albumin Price by Type (2018-2029)
5 Segment by Application
5.1 Global Plasma Albumin Sales by Application (2018-2029)
5.1.1 Global Plasma Albumin Sales by Application (2018-2023)
5.1.2 Global Plasma Albumin Sales by Application (2024-2029)
5.1.3 Global Plasma Albumin Sales Market Share by Application (2018-2029)
5.2 Global Plasma Albumin Revenue by Application (2018-2029)
5.2.1 Global Plasma Albumin Revenue by Application (2018-2023)
5.2.2 Global Plasma Albumin Revenue by Application (2024-2029)
5.2.3 Global Plasma Albumin Revenue Market Share by Application (2018-2029)
5.3 Global Plasma Albumin Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Grifols
6.1.1 Grifols Corporation Information
6.1.2 Grifols Description and Business Overview
6.1.3 Grifols Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Grifols Plasma Albumin Product Portfolio
6.1.5 Grifols Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Plasma Albumin Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Takeda Plasma Albumin Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Octapharma Plasma Albumin Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 CBPO
6.5.1 CBPO Corporation Information
6.5.2 CBPO Description and Business Overview
6.5.3 CBPO Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CBPO Plasma Albumin Product Portfolio
6.5.5 CBPO Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hualan Bio Plasma Albumin Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kedrion Plasma Albumin Product Portfolio
6.7.5 Kedrion Recent Developments/Updates
6.8 Shanghai RAAS
6.8.1 Shanghai RAAS Corporation Information
6.8.2 Shanghai RAAS Description and Business Overview
6.8.3 Shanghai RAAS Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Shanghai RAAS Plasma Albumin Product Portfolio
6.8.5 Shanghai RAAS Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Corporation Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 LFB Group Plasma Albumin Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 Biotest
6.10.1 Biotest Corporation Information
6.10.2 Biotest Description and Business Overview
6.10.3 Biotest Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Biotest Plasma Albumin Product Portfolio
6.10.5 Biotest Recent Developments/Updates
6.11 Tiantan Bio
6.11.1 Tiantan Bio Corporation Information
6.11.2 Tiantan Bio Plasma Albumin Description and Business Overview
6.11.3 Tiantan Bio Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Tiantan Bio Plasma Albumin Product Portfolio
6.11.5 Tiantan Bio Recent Developments/Updates
6.12 Shuanglin Bio
6.12.1 Shuanglin Bio Corporation Information
6.12.2 Shuanglin Bio Plasma Albumin Description and Business Overview
6.12.3 Shuanglin Bio Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Shuanglin Bio Plasma Albumin Product Portfolio
6.12.5 Shuanglin Bio Recent Developments/Updates
6.13 Boya Bio
6.13.1 Boya Bio Corporation Information
6.13.2 Boya Bio Plasma Albumin Description and Business Overview
6.13.3 Boya Bio Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Boya Bio Plasma Albumin Product Portfolio
6.13.5 Boya Bio Recent Developments/Updates
6.14 Yuanda Shuyang
6.14.1 Yuanda Shuyang Corporation Information
6.14.2 Yuanda Shuyang Plasma Albumin Description and Business Overview
6.14.3 Yuanda Shuyang Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Yuanda Shuyang Plasma Albumin Product Portfolio
6.14.5 Yuanda Shuyang Recent Developments/Updates
6.15 Weiguang Bio
6.15.1 Weiguang Bio Corporation Information
6.15.2 Weiguang Bio Plasma Albumin Description and Business Overview
6.15.3 Weiguang Bio Plasma Albumin Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Weiguang Bio Plasma Albumin Product Portfolio
6.15.5 Weiguang Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Albumin Industry Chain Analysis
7.2 Plasma Albumin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Albumin Production Mode & Process
7.4 Plasma Albumin Sales and Marketing
7.4.1 Plasma Albumin Sales Channels
7.4.2 Plasma Albumin Distributors
7.5 Plasma Albumin Customers
8 Plasma Albumin Market Dynamics
8.1 Plasma Albumin Industry Trends
8.2 Plasma Albumin Market Drivers
8.3 Plasma Albumin Market Challenges
8.4 Plasma Albumin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
